These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 12671031

  • 1. Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.
    Parhofer KG, Laubach E, Barrett PH.
    J Lipid Res; 2003 Jun; 44(6):1192-8. PubMed ID: 12671031
    [Abstract] [Full Text] [Related]

  • 2. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
    Parhofer KG, Barrett PH, Schwandt P.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4224-30. PubMed ID: 11095458
    [Abstract] [Full Text] [Related]

  • 3. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M.
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [Abstract] [Full Text] [Related]

  • 4. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [Abstract] [Full Text] [Related]

  • 5. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
    Boquist S, Karpe F, Danell-Toverud K, Hamsten A.
    Atherosclerosis; 2002 May; 162(1):163-70. PubMed ID: 11947910
    [Abstract] [Full Text] [Related]

  • 6. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
    Chan DC, Watts GF, Somaratne R, Wasserman SM, Scott R, Barrett PHR.
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
    [Abstract] [Full Text] [Related]

  • 7. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P, Heinonen T, Shurzinske L, Black DM.
    Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416
    [Abstract] [Full Text] [Related]

  • 8. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F, Hellénius ML, Hamsten A.
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [Abstract] [Full Text] [Related]

  • 9. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM, Berk-Planken II, Bootsma AH, Jansen H, Diabetes Atorvastatin Lipid intervention (DALI) Study Group.
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [Abstract] [Full Text] [Related]

  • 10. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J, Karpe F, Milne RW, Hamsten A.
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [Abstract] [Full Text] [Related]

  • 11. Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia.
    Empen K, Geiss HC, Lehrke M, Otto C, Schwandt P, Parhofer KG.
    Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):87-92. PubMed ID: 12929621
    [Abstract] [Full Text] [Related]

  • 12. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2002 Oct 01; 90(7):689-96. PubMed ID: 12356379
    [Abstract] [Full Text] [Related]

  • 13. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
    Burnett JR, Barrett PH, Vicini P, Miller DB, Telford DE, Kleinstiver SJ, Huff MW.
    Arterioscler Thromb Vasc Biol; 1998 Dec 01; 18(12):1906-14. PubMed ID: 9848883
    [Abstract] [Full Text] [Related]

  • 14. Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.
    Guerin M, Egger P, Le Goff W, Soudant C, Dupuis R, Chapman MJ.
    J Clin Endocrinol Metab; 2002 Nov 01; 87(11):4991-5000. PubMed ID: 12414863
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
    Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Keilson LM, Brown WV, Miller VT, Shurzinske LJ, Black DM.
    JAMA; 1996 Jan 10; 275(2):128-33. PubMed ID: 8531308
    [Abstract] [Full Text] [Related]

  • 16. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE.
    J Clin Endocrinol Metab; 2001 Jul 10; 86(7):3134-42. PubMed ID: 11443178
    [Abstract] [Full Text] [Related]

  • 17. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants.
    Krasinski SD, Cohn JS, Russell RM, Schaefer EJ.
    Metabolism; 1990 Apr 10; 39(4):357-65. PubMed ID: 2325560
    [Abstract] [Full Text] [Related]

  • 18. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C, Lilli S, Gentile A, Patti L, Di Marino L, Cipriano P, Riccardi G, Rivellese AA.
    Eur J Clin Invest; 2006 Aug 10; 36(8):560-5. PubMed ID: 16893378
    [Abstract] [Full Text] [Related]

  • 19. Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease.
    Dane-Stewart CA, Watts GF, Pal S, Chan D, Thompson P, Hung J, Mamo JC.
    Metabolism; 2003 Oct 10; 52(10):1279-86. PubMed ID: 14564679
    [Abstract] [Full Text] [Related]

  • 20. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
    Chan DC, Watts GF, Barrett PH, Martins IJ, James AP, Mamo JC, Mori TA, Redgrave TG.
    J Lipid Res; 2002 May 10; 43(5):706-12. PubMed ID: 11971941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.